Latest news
April 24, 2025
Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research
April 22, 2025
Debiopharm to Reveal Insights from their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at The 2025 AACR Conference in…
September 21, 2023
Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-Treat Cancers
September 22, 2022
Big Impact, Small Package: Debiopharm Launches a Wazoku Open-Innovation Challenge for Small Antibody Drug Conjugate Technology
February 25, 2021
Debiopharm and Genome & Company Join Forces to Create New Highly Specific Therapies For Cancer Patients